- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT04816253
Controlling Post-extraction Complications of Impacted Mandibular Third Molar
20. juli 2021 opdateret af: Alaa Altaweel, Al-Azhar University
Methylprednisolone and Hyaluronic Acid Versus Each Agent Alone to Control Post-extraction Complications of Impacted Mandibular Third Molar
Impacted mandibular 3rd molar will be extracted in all patients, then patients will be divided, according to material placed in extraction socket into 3 groups: control, hyaluronic acid and honey.
Then post extraction complications will be evaluated
Studieoversigt
Status
Afsluttet
Betingelser
Detaljeret beskrivelse
Impacted Mandibular third molar will be extracted under local anesthesia Through standard surgical flap elevation, after extraction and wound irrigation a material facilitate healing will be placed.
According to material will be placed patients will be divide into 3 group: control ( no material, second group hyaluronic acid, third group ( honey).. then wound will be closed.
Postoperative pain ( through visual analog scale) , edema, total dose of analgesic, mandibular movement (interincisal distance in mm) will be evaluated preoperative, 1,2,3,7, and 10 day after extraction
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
72
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
-
Jeddah, Saudi Arabien
- Vision college
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
20 år til 35 år (Voksen)
Tager imod sunde frivillige
Ja
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- healthy patients
- patient has impacted 3rd molar
Exclusion Criteria:
- medically compromised patients Heavy smoking patients
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Placebo komparator: Normal saline
Normal saline irrigation after extraction and No drug placed in tooth socket
|
Normal saline irrigation and No other drug placed after extraction
|
|
Aktiv komparator: Gengigel
Gengigel (Hyaluronic acid) placed after extraction
|
Immediately after removal of impacted tooth (hyaluronic acid) placed in extraction socket
Andre navne:
|
|
Aktiv komparator: Methylprednisolone
Methylprednisolone will be given intravenous to a patient half an hour before the surgery
|
Methylprednsolone will be injected half an hour preoperatively
|
|
Aktiv komparator: Methylprednisolone and Gengigel
Methylprednisolone will be given intravenous to a patient half an hour before the surgery and Gengigel (Hyaluronic acid) placed after extraction
|
Methylprednisolone will be injected half an hour preoperatively and Immediately after removal of impacted tooth (hyaluronic acid) placed in extraction socket
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Interincisal distance
Tidsramme: Baseline (Preoperative)
|
Measuring distance between upper lower anterior teeth in mm
|
Baseline (Preoperative)
|
|
Interincisal distance
Tidsramme: 1 day postoperative
|
Measuring distance between upper lower anterior teeth in mm
|
1 day postoperative
|
|
Interincisal distance
Tidsramme: 2nd day postoperative
|
Measuring distance between upper lower anterior teeth in mm
|
2nd day postoperative
|
|
Interincisal distance
Tidsramme: 3rd day postoperative
|
Measuring distance between upper lower anterior teeth in mm
|
3rd day postoperative
|
|
Interincisal distance
Tidsramme: 7th day postoperative
|
Measuring distance between upper lower anterior teeth in mm
|
7th day postoperative
|
|
Assessment of pain using Visual analog scale
Tidsramme: Baseline (Preoperative)
|
Patient asked to describe pain intensity subjectively on visual analog scale where 0 mean no pain while 10 mean sever pain
|
Baseline (Preoperative)
|
|
Assessment of pain using Visual analog scale
Tidsramme: 1st day
|
Patient asked to describe pain intensity subjectively on visual analog scale where 0 mean no pain while 10 mean sever pain
|
1st day
|
|
Assessment of pain using Visual analog scale
Tidsramme: 2nd day
|
Patient asked to describe pain intensity subjectively on visual analog scale where 0 mean no pain while 10 mean sever pain
|
2nd day
|
|
Assessment of pain using Visual analog scale
Tidsramme: 3rd day
|
Patient asked to describe pain intensity subjectively on visual analog scale where 0 mean no pain while 10 mean sever pain
|
3rd day
|
|
Assessment of pain using Visual analog scale
Tidsramme: 7th day
|
Patient asked to describe pain intensity subjectively on visual analog scale where 0 mean no pain while 10 mean sever pain
|
7th day
|
|
Total amount of analgesic
Tidsramme: 1st day postoperative
|
Total amount of analgesic Will be calculated
|
1st day postoperative
|
|
Total amount of analgesic
Tidsramme: 2nd day postoperative
|
Total amount of analgesic Will be calculated
|
2nd day postoperative
|
|
Total amount of analgesic
Tidsramme: 3rd day postoperative
|
Total amount of analgesic Will be calculated
|
3rd day postoperative
|
|
Total amount of analgesic
Tidsramme: 7th day postoperative
|
Total amount of analgesic Will be calculated
|
7th day postoperative
|
|
Size of edema will be assessed from finial angle and Travis of ear to mental ala of Nes and mouth angle
Tidsramme: Baseline
|
Edema measured from gonial angle and Tragus to mental, angle of mouth, ala of nose, and lateral canthus of eye respectively
|
Baseline
|
|
Size of edema will be assessed from finial angle and Travis of ear to mental ala of Nes and mouth angle
Tidsramme: 1st day postoperative
|
Edema measured from gonial angle and Tragus to mental, angle of mouth, ala of nose, and lateral canthus of eye respectively
|
1st day postoperative
|
|
Size of edema will be assessed from finial angle and Travis of ear to mental ala of Nes and mouth angle
Tidsramme: 2nd day postoperative
|
Edema measured from gonial angle and Tragus to mental, angle of mouth, ala of nose, and lateral canthus of eye respectively
|
2nd day postoperative
|
|
Size of edema will be assessed from finial angle and Travis of ear to mental ala of Nes and mouth angle
Tidsramme: 3rd day postoperative
|
Edema measured from gonial angle and Tragus to mental, angle of mouth, ala of nose, and lateral canthus of eye respectively
|
3rd day postoperative
|
|
Size of edema will be assessed from finial angle and Travis of ear to mental ala of Nes and mouth angle
Tidsramme: 7th day postoperative
|
Edema measured from gonial angle and Tragus to mental, angle of mouth, ala of nose, and lateral canthus of eye respectively
|
7th day postoperative
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
10. februar 2021
Primær færdiggørelse (Faktiske)
20. juni 2021
Studieafslutning (Faktiske)
20. juni 2021
Datoer for studieregistrering
Først indsendt
23. marts 2021
Først indsendt, der opfyldte QC-kriterier
24. marts 2021
Først opslået (Faktiske)
25. marts 2021
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
22. juli 2021
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
20. juli 2021
Sidst verificeret
1. juli 2021
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Stomatognatiske sygdomme
- Tandsygdomme
- Tand, påvirket
- Lægemidlers fysiologiske virkninger
- Autonome agenter
- Agenter fra det perifere nervesystem
- Anti-inflammatoriske midler
- Antineoplastiske midler
- Immunologiske faktorer
- Antiemetika
- Gastrointestinale midler
- Glukokortikoider
- Hormoner
- Hormoner, hormonsubstitutter og hormonantagonister
- Antineoplastiske midler, hormonelle
- Neuroprotektive midler
- Beskyttelsesagenter
- Adjuvanser, immunologiske
- Viskostilskud
- Prednisolon
- Methylprednisolonacetat
- Methylprednisolon
- Methylprednisolon Hemisuccinat
- Prednisolonacetat
- Prednisolon hemisuccinat
- Prednisolonfosfat
- Hyaluronsyre
Andre undersøgelses-id-numre
- Extraction healing
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Preventing Postextraction Complication
-
Kahramanmaras Sutcu Imam UniversityAfsluttetFedme, sygelig | Perioperativ komplikation | BMD | Laparaskopisk ærmegatrektomi | Fedmekirurgi Dødelighedsscore | Clavien Dindo Surgical Complication Scale
-
Ondokuz Mayıs UniversityIkke rekrutterer endnuObstruktion af blæreudløb | Nedre urinvejssymptomer (LUTS) | Benign prostataforstørrelse (BPE) | Clavien Dindo Surgical Complication Scale | Urininkontinens efter kirurgisk indgreb | Trifecta -præstation | HolepTyrkiet (Türkiye)
Kliniske forsøg med Normal saline
-
Ain Shams UniversityAfsluttetKejsersnitsår | Kirurgisk infektion i operationsområdet (SSI)Egypten
-
Multan Medical And Dental CollegeAfsluttetDiabetisk fodsår | Kronisk hudsårPakistan
-
Ankara City Hospital BilkentAfsluttetSedation | ERCP | Duodenal SpasmeTyrkiet (Türkiye)
-
Universitätsklinikum Hamburg-EppendorfIkke rekrutterer endnu
-
PAEC General Hospital, IslamabadAfsluttetPåvirket mandibular tredje molar ekstraktionPakistan
-
Haukeland University HospitalIkke rekrutterer endnuKronisk nyresygdom, der kræver kronisk dialyse | Kardiovaskulær forkalkningNorge
-
Rawalpindi Medical CollegeAfsluttetPostoperativ kvalme og opkastning (PONV)Pakistan
-
PfizerRekrutteringClostridioides Difficile-associeret SygdomForenede Stater, Japan, Det Forenede Kongerige, Argentina
-
National Taiwan University HospitalTaichung Veterans General Hospital; Miaoli General Hospital, Ministry of...Tilmelding efter invitation
-
Universitätsklinikum Hamburg-EppendorfIkke rekrutterer endnuForventningseffekter på følelsesmæssig behandlingTyskland